The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
You are here Home Guidance and resources Sponsors Hetero Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share Loading... Type Prescription medicine registration (1) Prescription medicine registration (1) Date 2019 (1) (-) 2019 (1) 2022 (15) 2022 (15) 2021 (4) 2021 (4) 2020 (2) 2020 (2) 2018 (10) 2018 (10) 2017 (24) 2017 (24) 2015 (6) 2015 (6) 2014 (1) 2014 (1) Show more Search Filters applied:2019Clear all Sponsor content1 result(s) found, displaying 1 to 1 CAVADEXA , ABADINE, ABALAMID HETERO , BACAMID, LAMAVIR 600/300 (Hetero Australia Pty Ltd) 18 February 2019 Prescription medicine registration Active ingredients: Lamivudine, Abacavir sulfate.
CAVADEXA , ABADINE, ABALAMID HETERO , BACAMID, LAMAVIR 600/300 (Hetero Australia Pty Ltd) 18 February 2019 Prescription medicine registration Active ingredients: Lamivudine, Abacavir sulfate.